Fundz

Ouro Medicine raised $120M in a Series A funding led by GSK to develop drugs that reset the immune system.

PRIVATEJan 10, 2025

Amount Raised

$120 Million

Round Type

Series A

San FranciscoBiotechnologyHealth CareTherapeutics

Investors

Monograph CapitalGsk

Description

Ouro Medicine, based in San Francisco, has emerged from stealth revealing $120 million in funding. The company aims to create drugs that provide a durable remission for autoimmune diseases without chronic immunosuppression.

Quick answer

Ouro Medicine raised $120 Million in a Series A round, dated January 10, 2025. Investors: Monograph Capital and Gsk. Ouro Medicine is based in San Francisco, California, United States.

How much did Ouro Medicine raise?
Ouro Medicine raised $120 Million in a Series A round on January 10, 2025.
Who invested in Ouro Medicine?
Monograph Capital and Gsk are named as investors in this round.
What does Ouro Medicine do?
Ouro Medicine is an immunology startup focused on developing drug candidates that can reset the immune system to treat autoimmune diseases.
Where is Ouro Medicine based and how big is it?
Ouro Medicine is based in San Francisco, California, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Ouro Medicine that raised within 45 days of this round, from Fundz verified event records.

  • Solid IO raised $839K (Seed) on February 24, 2025.
  • Humane Genomics raised an undisclosed amount (Seed) on February 21, 2025.
  • Ceretas raised $1M (Seed) on February 21, 2025.
  • Reverb Therapeutics raised $12M (Seed) on February 19, 2025.
  • MAIA Biotechnology raised $4.1M (Seed) on February 18, 2025.
  • Bambusa Therapeutics raised $90M (Series A) on February 14, 2025.

Who to call at Ouro Medicine, and when

A new round usually means Ouro Medicine is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ouro Medicine raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ouro Medicine, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ouro Medicine. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ouro Medicine

Location

San Francisco, California, United States

About

Ouro Medicine is an immunology startup focused on developing drug candidates that can reset the immune system to treat autoimmune diseases. The company's therapies utilize T cell engagers (TCEs) to simultaneously target disease-driving cells and enhance the immune response. With a vision to facilitate durable remission without chronic immunosuppression, Ouro aims to change traditional treatment paradigms in medicine.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ouro Medicine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Ouro Medicine's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Ouro Medicine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.